The role of extracellular vesicles in COPD and potential clinical value

Shasha Liu,Xiaowu Tan,Sha Liu
DOI: https://doi.org/10.1186/s12931-024-02719-z
IF: 5.8
2024-02-11
Respiratory Research
Abstract:Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung disease and a major health burden worldwide. Extracellular vesicles (EVs) are nanosized vesicles which possess a lipid bilayer structure that are secreted by various cells. They contain a variety of bioactive substances, which can regulate various physiological and pathological processes and are closely related to the development of diseases. Recently, EVs have emerged as a novel tool for intercellular crosstalk, which plays an essential role in COPD development. This paper reviews the role of EVs in the development of COPD and their potential clinical value, in order to provide a reference for further research on COPD.
respiratory system
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the pathological role of extracellular vesicles (EVs) in the development of chronic obstructive pulmonary disease (COPD) and their potential clinical value. Specifically, the paper focuses on the following aspects: 1. **Inflammation**: To study how EVs promote the pathogenesis of COPD by transporting pro - inflammatory mediators or inflammatory substances to other cells. For example, the level of exosomes in the blood of COPD patients is significantly higher than that of healthy individuals, and these exosomes are positively correlated with inflammatory markers (such as C - reactive protein, soluble tumor necrosis factor receptor type I, interleukin - 6). 2. **Protease - antiprotease imbalance**: To explore the role of EVs in regulating the protease and antiprotease system, especially by activating or transporting substances related to proteases and antiproteases. For example, neutrophil - derived EVs assist neutrophil elastase (NE) to bypass the antiprotease protection barrier in the lungs, leading to the destruction of the extracellular matrix and then causing emphysema. 3. **Oxidative stress**: To analyze the role of EVs in oxidative stress, especially in affecting mitochondrial function. For example, after treatment with lymphocyte - derived microparticles (LMPs), the levels of malondialdehyde, superoxide anions and reactive oxygen species (ROS) in cells are significantly increased, while the production of the antioxidant glutathione is inhibited. 4. **Autoimmune response**: To explore the role of EVs in the autoimmune response of COPD, including regulating immune cells by transporting relevant immunomodulatory molecules. For example, alveolar macrophages in COPD patients transport miRNA233 to various respiratory cells through EVs to regulate the innate immune response. 5. **Cell senescence**: To study the role of EVs in cell senescence, especially by transporting miRNAs related to senescence to transmit cell senescence signals. For example, the expression of miR - 21 secreted by EVs is increased in senescent cells in vitro and may trigger the senescence process of surrounding cells. 6. **Biomarker potential**: To evaluate the potential of EVs as biomarkers for COPD, especially their applications in diagnosis, monitoring disease progression and evaluating treatment responses. For example, the level of circulating endothelial microparticles (EMPs) is significantly increased in COPD patients and can be used for early identification of disease progression. 7. **Therapeutic potential**: To explore the potential applications of EVs in the treatment of COPD, especially by inhibiting inflammation and improving mitochondrial function. For example, EVs derived from mesenchymal stromal cells (MSCs) show a protective effect on cigarette - induced inflammation and mitochondrial dysfunction in mouse models. In summary, this paper aims to comprehensively summarize the role of EVs in the pathogenesis of COPD and their potential as biomarkers and treatment means, providing references for future research and clinical applications.